View Exam | PowerPak

1. Based on current risk estimates, how many African American men who have sex with men (MSM) will acquire HIV in their lifetimes?

A. 1 in 2 B. 1 in 4 C. 1 in 10 D. 1 in 25

2. Which of the following is/are approved by the US Food and Drug Administration for HIV preexposure prophylaxis (PrEP)?

A. Tenofovir disoproxil fumarate (TDF) B. TDF + lamivudine (3TC) C. TDF + emtricitabine (FTC) D. Tenofovir alafenamide (TAF) + emtricitabine (FTC) E. Both TDF/FTC and TAF/FTC

3. Which of the following patient profiles would NOT meet CDC recommendations for immediate discussion of HIV PrEP and determination of PrEP eligibility?

A. An HIV-negative 23-year-old MSM who was treated for chlamydia 3 months ago B. An HIV-negative 35-year-old woman who has been having a casual sexual relationship with a bisexual man for 4 months C. An HIV-negative, newly sexually active, 19-year-old MSM who 2 months ago had unprotected anal-receptive sex twice with an experienced partner D. A 44-year-old HIV-negative woman who injects heroin and has presented regularly to the pharmacy over the last year to exchange her once-used needles and syringes for sterile paraphernalia

4. A 32-year-old man who has now been on PrEP (TDF/FTC) for 6 months presents to the pharmacy for routine on-PrEP monitoring. Per CDC/USPHS guidelines, which of the following laboratory tests should be performed for this patient at 6-month intervals, starting with today's encounter?

A. Hepatitis B (HBV) serology B. Hepatitis C (HCV) serology C. HIV status D. Estimated creatinine clearance (eCrCl)

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Based on current risk estimates, how many African American men who have sex with men (MSM) will acquire HIV in their lifetimes?

2. Which of the following is/are approved by the US Food and Drug Administration for HIV preexposure prophylaxis (PrEP)?

3. Which of the following patient profiles would NOT meet CDC recommendations for immediate discussion of HIV PrEP and determination of PrEP eligibility?

4. A 32-year-old man who has now been on PrEP (TDF/FTC) for 6 months presents to the pharmacy for routine on-PrEP monitoring. Per CDC/USPHS guidelines, which of the following laboratory tests should be performed for this patient at 6-month intervals, starting with today's encounter?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Based on current risk estimates, how many African American men who have sex with men (MSM) will acquire HIV in their lifetimes?

2. Which of the following is/are approved by the US Food and Drug Administration for HIV preexposure prophylaxis (PrEP)?

3. Which of the following patient profiles would NOT meet CDC recommendations for immediate discussion of HIV PrEP and determination of PrEP eligibility?

4. A 32-year-old man who has now been on PrEP (TDF/FTC) for 6 months presents to the pharmacy for routine on-PrEP monitoring. Per CDC/USPHS guidelines, which of the following laboratory tests should be performed for this patient at 6-month intervals, starting with today's encounter?

« Return to Activity

Customers who Purchased
this Activity also Purchased